Protein microarray analysis in patients with asthma : Elevation of the chemokine PARC/CCL18 in sputum

Chest

Volumn 135, Issue 2, 2009, Pages 295-302

  Kim, Hyo Bin ^a   Kim, Chang Keun ^a   Iijima, Koji ^b   Kobayashi, Takao ^b   Kita, Hirohito ^b,c  

^a Inje University College of Medicine   (South Korea)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Asthma; Cytokine microarray analysis; Eosinophilic inflammation; Pulmonary and activation regulated chemokin CCL18

Indexed keywords

CORTICOSTEROID; CYTOKINE; EOSINOPHIL PROTEIN X; EOTAXIN 2; GAMMA INTERFERON; INTERLEUKIN 4; NEUROTOXIN; PROTEIN PARC; SALBUTAMOL;

AIRWAY; ARTICLE; ASTHMA; BACTERIAL GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GAS; HUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; RADIOIMMUNOASSAY; SCREENING; STATISTICAL SIGNIFICANCE; SUPERNATANT; T LYMPHOCYTE; TECHNOLOGY;

EID: 60249102611     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-0962     Document Type: Article

References (47)

1. Pizzichini E, Pizzichini MM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317
2. Spanevello A, Migliori GB, Sharara A, et al. Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy 1997; 27:1138-1144
3. Claman DM, Boushey HA, Liu J, et al. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994; 94:861-869
4. MacBeath G. Protein microarrays and proteomics. Nat Genet 2002; 32:S526-S532
5. Fahy JV, Liu J, Wong H, et al. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147:1126-1131
6. Carlson M, Hakansson L, Peterson C, et al. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991; 87:27-33
7. Kodadek T. Protein microarrays: prospects and problems. Chem Biol 2001; 8:105-115
8. Kay AB. Allergy and allergic diseases: first of two parts. N Engl J Med 2001; 344:30-37
9. D'Ambrosio D, Iellem A, Bonecchi R, et al. Selective up- regulation of chemokine receptors CCD4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998; 161:5111-5115
10. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277:2005-2007
11. Peasse JE, Weller CL, Williams TJ. Regulation of eosinophil trafficking in asthma and allergy. Ernst Schering Res Found Workshop 2004; 99:85-100
12. Bisset LR, Schmid-Grendelmeier R. Chemokines and their receptors in the pathogenesis ofallergic asthma: progress and perspective. Curr Opin Pulm Med 2004; 11:35-42
13. Forssmann U, Uguccioni M, Loetscher P, et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997; 185:2171-2176
14. White JR, Imburgia C, Dul E, et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophil. J Leu-koc Biol 1997; 62:667-675
15. Ying S, Robinson DS, Meng Q, et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other CC chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 1999; 163:3976-3984
16. Rankin SM, Conroy DM, Williams TJ. Eotaxin and eosinophil recruitment: implications for human diseases. Mol Med Today 2000; 6:20-27
17. Scheicher EM, Teixeira MM, Cunha FQ, et al. Eotaxin-2 in sputum cell culture to evaluate asthma inflammation. Eur Respir J 2007; 29:489 -495
18. Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol 2002; 22:105-114
19. Alam R. Chemokines in cell movement and inflammation. In: Adkinson NF Jr, Yunginger JW, Busse WW, et al, eds. Middleton's allergy principles & practice. 6th ed. St. Louis, MO: Mosby, 2003; 159-176
20. Baruch A, Oppenheim JJ, Proost P, et al. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 1997; 36:2716-2723
21. Koch AE, Kunkel SL, Shah MR, et al. Growth-related gene product alpha: a chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995; 155:3660-3666
22. van Damme J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells: in vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol 1993; 150:1000-1015
23. Prause O, Laan M, Lotvall J, et al. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-α- and interleukin-8 release in human bronchial epithelial cells: Eur J Pharmacol 2003; 462:193-198
24. Hieshima K, Imai T, Baba M, et al. A novel human CC chemokine PARC that is most homologous to macrophage- inflammatory protein-1 α/LD78 α and chemotactic for T lymphocytes, but not for monocytes. J Immunol 1997; 159: 1140-1149
25. Adema GJ, Hartgers F, Verstraten R, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naïve T cells. Nature 1997; 387:713-717
26. Kodelja V, Muller C, Politz O, et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1-α with a Th2-associated expression pattern. J Immunol 1998; 160: 1411-1418
27. Guan P, Burghes AH, Cunningham A, et al. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/ SCYA18. Genomics 1999; 56:296-302
28. de Nadai P, Charbonnier A, Chenivesse C, et al. Involvement of CCL18 in allergic asthma. J Immunol 2006; 176:6286-6293
29. Reape TJ, Rayner K, Manning CD, et al. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol 1999; 154:365-374
30. Schutyser E, Struyf S, Wuyts A, et al. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur J Immunol 2001; 31:3755-3762
31. Goebeler M, Trautmann A, Voss A, et al. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol 2001; 158:431-440
32. Pardo A, Smith KM, Abrams J, et al. CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J Leu-kocyte Biol 2001; 70:610-616
33. Gunther C, Bello-Fernandez C, Kopp T, et al. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 2005; 174:1723-1728
34. Nomura I, Gao B, Boguniewicz M, et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003; 112:1195-1202
35. Pivarcsi A, Gombert M, Dieu-Nosjean MC, et al. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J Immunol 2004; 173:5810-5817
36. Vissers JL, Hartgers FC, Lindhout E, et al. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukoc Biol 2001; 69:785-793
37. Schraufstatter I, Takamori H, Sikora L, et al. Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages. Am J Physiol 2004; 286:L494-L501
38. Lindhout E, Vissers JL, Hartgers FC, et al. The dendritic cell-specific CC-chemokine DC-CK1 is expressed by germinal center dendritic cells and attracts CD38-negative mantle zone B lymphocytes. J Immunol 2001; 166:3284-3289
39. Vulcano M, Struyf S, Scapini P, et al. Unique regulation of CCL18 production by maturing dendritic cells. J Immunol 2003; 170:3843-3849
40. Mazzarella G, Bianco A, Catena E, et al. Th1/Th2 lymphocyte polarization in asthma. Allergy 2000; 55:S6-S9
41. Iwamoto I, Nakajima H, Endo H, et al. Interferon γ regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993; 177:573-576
42. Li XM, Chopra RK, Chou TY, et al. Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J Immunol 1996; 157:3216-3219
43. Cho SH, Stanciu LA, Holgate ST, et al. Increased interleukin-4, interleukin-5, and interferon-γ in airway CD4+ and CD8+ cells in atopic asthma. Am J Respir Crit Care Med 2005; 171:224-230
44. Randolph DA, Carruthers CJ, Szabo SJ, et al. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162:2375-2383
45. Hansen G, Berry G, DeKruyff RH, et al. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-183
46. Randolph DA, Stephen R, Carruthers CJ, et al. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999; 104:1021-1029
47. Nakajima H, Takatsu K. Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 2007; 142:265-273